Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Current Assets (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Current Assets readings, the most recent being $132.1 million for Q4 2025.

  • On a quarterly basis, Current Assets fell 18.18% to $132.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $132.1 million, a 18.18% decrease, with the full-year FY2025 number at $132.1 million, down 18.18% from a year prior.
  • Current Assets hit $132.1 million in Q4 2025 for Treace Medical Concepts, down from $138.0 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $223.1 million in Q1 2023 to a low of $36.5 million in Q1 2021.
  • Median Current Assets over the past 5 years was $144.2 million (2021), compared with a mean of $151.3 million.
  • Biggest five-year swings in Current Assets: skyrocketed 249.25% in 2022 and later dropped 20.26% in 2025.
  • Treace Medical Concepts' Current Assets stood at $138.0 million in 2021, then fell by 3.31% to $133.4 million in 2022, then surged by 48.69% to $198.4 million in 2023, then fell by 18.63% to $161.4 million in 2024, then fell by 18.18% to $132.1 million in 2025.
  • The last three reported values for Current Assets were $132.1 million (Q4 2025), $138.0 million (Q3 2025), and $147.6 million (Q2 2025) per Business Quant data.